QGC-001

DB13107InvestigationalSmall molecule

QGC001 has been used in trials studying the treatment of Essential Hypertension.

Chemical structure of QGC-001
Mechanism
Curator reviewed
Formula / weight
C8H20N2O6S4 · 368.5 g/mol (avg)
Also known as
Firibastat
Code names
QGC-001 · RB-150

Resolves to

Compound
UNII638KY4573ICAS648927-86-0PubChem24851355
Structure
InChIKeyHJPXZXVKLGEMGP-YUMQZZPRSA-NSMILESN[C@@H](CCS(O)(=O)=O)CSSC[C@@H](N)CCS(O)(=O)=O
Targets
Q07075ENPEPQ9ULA0DNPEP

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with QGC-001, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In